Skip to content
Search

Dems Prove What Other Countries Know: Negotiating Drug Prices Works

Dems Prove What Other Countries Know: Negotiating Drug Prices Works

Medicare has completed its first-ever negotiations with pharmaceutical companies over drug prices. Though only 10 drugs were part of the initial program, the Biden administration announced on Thursday that Medicare will save $6 billion and Americans will save $1.5 billion in out-of-pocket costs in the program’s first year.

Congress for decades prohibited Medicare from negotiating drug prices, something that virtually all other countries do. It’s a chief reason why drug prices are two to four times higher in the United States than in other wealthy countries. The negotiated price list released by the administration on Thursday shows what Americans have been missing out on: Medicare will pay less than half of the current list prices on nine of the first 10 drugs that were included in the program. 


“For years, millions of Americans were forced to choose between paying for medications or putting food on the table, while Big Pharma blocked Medicare from being able to negotiate prices on behalf of seniors and people with disabilities,” President Joe Biden said in a statement. “But we fought back — and won.”

The fight is far from over: The negotiated prices will go into effect in 2026; several drugmakers and lobbying groups have sued to try to block the Medicare negotiation program, while Republican lawmakers are eager to repeal it.  

The pharmaceutical industry is one of the most powerful and well-funded interest groups in Washington. Its lobbyists have long argued that negotiating drug prices would harm patients, limit access to medicines, and stifle innovation, even though the U.S. government helps fund research and development on all drugs that are approved for sale. 

The basic reality is that Americans have been forced to pay the world’s highest prices for lifesaving products they helped finance. This status quo remains, but under Biden, Democrats finally fulfilled their longtime pledge to allow Medicare to negotiate drug prices. Some conservative Democrats helped water down the provision — limiting the number and types of drugs that would be subject to negotiation, and who will benefit — but the program’s successful inclusion as part of the 2022 Inflation Reduction Act was historic — and it opens the door to further expansions down the line. 

During this year’s State of the Union speech, for instance, Biden called on Congress to “give Medicare the power to negotiate lower prices for 500 drugs over the next decade.” During her first campaign rally as the presumptive Democratic presidential nominee, Vice President Kamala Harris pledged to “take on Big Pharma to cap prescription drug costs for all Americans.”

Biden and Harris will hold a joint event in Maryland on Thursday touting the administration’s efforts to lower costs for the American people. The Harris campaign said she will announce a policy proposal on Friday pertaining to prescription drug costs.

Per the terms of the IRA, the Medicare drug negotiation program started with 10 expensive, older drugs that have no generic competition despite being on the market for at least nine years. The first round included drugs used to prevent blood clotting, reduce the risk of stroke, and treat diabetes, heart failure, blood cancers, Crohn’s disease, and plaque psoriasis.

As The Lever previously reported, the 10 drugs have all been sold in other countries at far lower prices. 

One such drug is Januvia, a pill from Merck that helps adults with type 2 diabetes lower their blood sugar levels. A 2019 report by House Democrats found that Januvia was priced 1,000 percent higher in the U.S. than in international markets on average. Notably, the U.S. National Institutes of Health provided $228 million in funding for research prior to Januvia’s approval.

According to the Biden administration’s negotiated price list, the 2023 list price for a 30-day supply of Januvia was $527. In 2026, Medicare will instead pay $113 — or 79 percent less. 

Xavier Becerra, Health and Human Services Secretary, celebrated the price negotiations in an interview with Rolling Stone, noting that the U.S. is going to save billions on “just this first negotiation on 10 drugs,” when there thousands of drugs covered under Medicare.

“If you look at it, if we can bring [one] price down by some 79 percent, why have we been paying these high prices so long, and how much should we actually be paying, and how many more drugs will we find that we can reduce the price of, if we just expand this program?” he said.

Merck launched the first lawsuit to block the Biden administration’s Medicare drug negotiation program, calling it “tantamount to extortion” and arguing that “it violates the Constitution.” Several drug industry lawsuits seeking to block the drug negotiation program have failed. Merck’s case is still pending.

“Every company that is suing us is also negotiating with us,” said Becerra. “Every company that negotiated with us agreed on a price. In some cases, we accepted an offer or counter offer that they came up with, and in the other cases, they accepted the offer [or] counter offer that we came up with. But either way, they agreed.”

He added, “We voluntarily came to an agreement on the price — even though they are suing us. And by the way, every lawsuit that they have filed so far, they haven’t won one.”

More Stories

The Rise of the Digital Oligarchy
Illustration by Matthew Cooley. Photographs in illustration by Julia Demaree Nikhinson/POOL/AFP/Getty Images; The White House; Adobe Stock

The Rise of the Digital Oligarchy

On Jan. 11, 1994, I drove to UCLA’s Royce Hall to hear Vice President Al Gore deliver the keynote address at the Information Superhighway Conference. I was in the early stages of building Intertainer, which would become one of the first video-on-demand companies. The 2,000 people crowded into that auditorium did not know it, but they were crossing a threshold. The roster of speakers read like a who’s who of industrial power: TCI’s John Malone, Rupert Murdoch, Sony’s Michael Schulhof, Barry Diller of QVC. These were among the richest and most commanding figures in American communications. Today, their combined force and fortunes are a rounding error beside Elon Musk, Mark Zuckerberg, Peter Thiel, Jensen Huang, Jeff Bezos, and Marc Andreessen. The world the Hollywood moguls walked back out into would not, in any meaningful sense, be the world they had left.

Keep ReadingShow less
Bernie Sanders and AOC Want to Pump the Brakes on AI Development

Rep. Alexandria Ocasio-Cortez (D-N.Y.) and U.S. Sen. Bernie Sanders (I-Vt.) in April 2025.

Natalie Behring/Getty Images

Bernie Sanders and AOC Want to Pump the Brakes on AI Development

Senator Bernie Sanders and Representative Alexandria Ocasio-Cortez are announcing their support for two new AI bills aimed at putting a federal moratorium on the constructions of data centers. Sanders is introducing his bill, the AI Data Center Moratorium Act, on Wednesday.

“AI and robotics are creating the most sweeping technological revolution in the history of humanity. Congress is way behind where it should be in understanding the nature of this revolution and its impacts,” Sanders says in a statement to Rolling Stone. “We cannot sit back and allow a handful of billionaire Big Tech oligarchs to make decisions that will reshape our economy, our democracy and the future of humanity. We need serious public debate and democratic oversight over this enormously consequential issue.”

Keep ReadingShow less
Top Trump Official Resigns Over Iran War: ‘No Imminent Threat’

Joe Kent, director of the National Counterterrorism Center, testifies on Wednesday, Dec. 11, 2025.

Tom Williams/CQ-Roll Call, Inc/Getty Images

Top Trump Official Resigns Over Iran War: ‘No Imminent Threat’

The director of the National Counterterrorism Center resigned from his post on Tuesday in protest of Donald Trump’s ongoing war against Iran. Joe Kent, a former Army Ranger and CIA paramilitary officer, announced that he “cannot in good conscience support” the war, and that Iran was not an imminent threat to the United States, which the president and his administration have claimed in order to justify attacking the nation.

“Iran posed no imminent threat to our nation, and it is clear that we started this war due to pressure from Israel and its powerful American lobby,” Kent wrote in a statement released through his office and circulated on social media. “As a veteran who deployed to combat 11 times and as a Gold Star husband who lost my beloved wife Shannon in a war manufactured by Israel, I cannot support sending the next generation off to fight and die in a war that serves no benefit to the American people nor justifies the cost of American lives.”

Keep ReadingShow less
Trump Says Iran War Is Both ‘Very Complete’ But Also Just ‘the Beginning’

President Donald Trump at the Republican Members Issues Conference in Florida on March 9, as the war in Iran continues

Roberto Schmidt/Getty Images

Trump Says Iran War Is Both ‘Very Complete’ But Also Just ‘the Beginning’

As the U.S.-Israeli war on Iran escalates, President Donald Trump and his Cabinet have offered a litany of dizzying updates on the conflict.

During a phone interview with CBS News on Monday, Trump said the war with Iran is “very complete, pretty much.” Speaking from his Doral, Florida, golf club, the president claimed “[Iran has] no navy, no communications, they’ve got no air force. Their missiles are down to a scatter. Their drones are being blown up all over the place, including their manufacturing of drones.” He added, “If you look, they have nothing left. There’s nothing left in a military sense.”

Keep ReadingShow less
Trump Fires Kristi Noem, Taps Oklahoma Senator to Lead DHS

Kristi Noem testifies before the House Judiciary Committee in the Rayburn House Office Building on March 4, 2026 in Washington, D.C.

Heather Diehl/Getty Images

Trump Fires Kristi Noem, Taps Oklahoma Senator to Lead DHS

After weeks of public scrutiny, personal scandal, and bad press over her handling of the Department of Homeland Security, President Donald Trump has fired Secretary Kristi Noem, tapping Oklahoma Senator Markwayne Mullin as her potential replacement.

Noem is the first member of Trump’s second-term Cabinet to be removed from their position. In a statement posted to Truth Social on Thursday, Trump wrote that he was “pleased to announce that the Highly Respected United States Senator from the Great State of Oklahoma, Markwayne Mullin, will become the United States Secretary of Homeland Security (DHS), effective March 31, 2026.”

Keep ReadingShow less